comparemela.com
Home
Live Updates
Palatin Issued Patent on Vyleesi® (Bremelanotide Injection) For Hypoactive Sexual Desire Disorder in Patients With Controlled Hypertension : comparemela.com
Palatin Issued Patent on Vyleesi® (Bremelanotide Injection) For Hypoactive Sexual Desire Disorder in Patients With Controlled Hypertension
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
Related Keywords
China ,
Kwangdong ,
Ch Ungch Ong Bukto ,
South Korea ,
United States ,
American ,
Carl Spana ,
Fosun Pharma ,
Trademark Office ,
Kwangdong Pharmaceuticals ,
Prnewswire Palatin Technologies Inc ,
United States Patent ,
Uncontrolled Hypertension ,
Hypoactive Sexual Desire Disorder ,
Palatin Technologies ,
Nc ,
comparemela.com © 2020. All Rights Reserved.